See All Slides - tctmd.com

Slides

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

PROPHET II Trial Summary and Clinical Implications

Presenter: Prashant Kaul, Jennifer A. Tremmel, Samir B. Pancholy

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Michael J. Mack, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation TCT 2017

Bifurcation Literature Review: New Data From 2016-17

Presenter: Davide Capodanno, David Hildick-Smith, Tom Johnson

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of VKA and NOACs in Clinical Practice

Presenter: Christopher B. Granger, Horst Sievert

October 30, 2017

Presentation TCT 2017

A Conceptual Framework for Selection of MR Patients for Medical Therapy, Surgery, and Transcatheter Therapies

Presenter: Paul A. Grayburn, Maurice E. Sarano, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Presenter: Mitchell W. Krucoff, John C Laschinger, E. Murat Tuzcu

October 30, 2017

Advertisement

Slides

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

PROPHET II Trial Summary and Clinical Implications

New U.S. Hypertension Guidelines and Treatment Targets

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Bifurcation Literature Review: New Data From 2016-17

Strengths and Limitations of VKA and NOACs in Clinical Practice

A Conceptual Framework for Selection of MR Patients for Medical Therapy, Surgery, and Transcatheter Therapies

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content